Table 3.
Relationship between Bax (-248G > A) polymorphism and known clinicopathological variables
|
Clinicopathological Variables
|
|
Genotypes
|
Adjusted
|
|
|
|---|---|---|---|---|---|
| All | AG | P-value | GG | OR | |
| Age | |||||
| ≥ 45 | 11 | 2 | 9 | 1.00 | |
| > 45 | 89 | 29 | 0.0290* | 60 | 2.255 |
| Gender | |||||
| Male | 76 | 21 | 55 | 1.00 | |
| Female | 24 | 8 | 0.0001** | 16 | 12.341 |
| Habit | |||||
| Cigarette smokers | 23 | 9 | 14 | 1.00 | |
| Non-smokers | 45 | 16 | 0.8117 | 29 | 0.836 |
| Stage | |||||
| I, II | 19 | 8 | 11 | 1.00 | |
| III, IV | 54 | 19 | 0.7867 | 35 | 0.731 |
| Tumor Grade | |||||
| I, II | 24 | 13 | 11 | 1.00 | |
| III | 24 | 11 | 0.5642 | 13 | 1.397 |
All statistical tests were two-sided with a significance level of p≤0.05.
*
Logistic regression model, adjusted for diagnostic age. NTM Stage: I, II, III, IV